TY - JOUR
TI - Brexucabtagene autoleucel for mantle cell lymphoma, B-cell precursor acute lymphoblastic leukaemia
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2023
VL - 46
IS - 2
SP - 40
EP - 41
DO - 10.18773/austprescr.2023.011
LA - eng
UR - https://australianprescriber.tg.org.au/articles/brexucabtagene-autoleucel-for-mantle-cell-lymphoma-b-cell-precursor-acute-lymphoblastic-leukaemia.html
KW - B-cell precursor acute lymphoblastic leukaemia
KW - brexucabtagene autoleucel
KW - mantle cell lymphoma
KW - Tecartus
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -